ANVISA registration 81285200024Valid until Jun 16, 2035

ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)

Name: ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) — ANVISA registration 81285200024
Creator: BEIJING HOTGEN BIOTECH CO., LTD.
Keywords: ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2), ANTICORPO PARA VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 E TIPO 2 (HIV 1 E HIV 2), Teste Rápido Anti-HIV 1 e 2 Bahiafarma (Ouro Coloidal), 81285200024, Risk Class IV, ANVISA registration

ANVISA Registration Number: 81285200024FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMABEIJING HOTGEN BIOTECH CO., LTD.Risk Class IV

Verified

Device names

Technical name: ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
Commercial name: Teste Rápido Anti-HIV 1 e 2 Bahiafarma (Ouro Coloidal)
Risk class: Class IV

Registration details

Registration Number: 81285200024
Process Number: 25351315229202472
CNPJ: 13078518000190

Company information

Registration Holder: FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA
Manufacturer: BEIJING HOTGEN BIOTECH CO., LTD.
Manufacturing Country: China

Dates and status

Publication Date: Jun 16, 2025
Validity: 16/06/2035
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81285200024 and manufactured by BEIJING HOTGEN BIOTECH CO., LTD.. The registration is held by FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA with validity until Jun 16, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.